In a recent study published on the medRxiv* preprint server, researchers validate a quick, highly efficient, and automated assay to detect neutralizing antibodies (nAb) against the severe acute ...

Biomedical research faces a ubiquitous and fundamental challenge: Because the goal of the research is to improve human health, the human body is logically the best place to perform experiments.

In a recent prospective study published on the medRxiv* preprint server, researchers examine the effects of disease-modifying therapies (DMTs) implemented for treating multiple sclerosis (MS) on the ...

Whether They Are Used In Drug Screens or Precision Medicine, Cell-Based Assays Are All About Context Cells are miniature laboratories that allow scientists to study key biological processes. As a ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Accure Health, a developer of rapid digital diagnostics, today announced the online publication of preliminary data showing that its novel saliva assay can assess ...

A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform. Subscribe to our newsletter for the latest sci-tech news updates ...

Scientists need cellular assay technologies that examine multiple parameters at the same time, optimize high throughput workflows, control atmospheric conditions, and reduce experimental variability.

Promega Corporation launched a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...

New Assay Evaluates Neutralizing Anti-IFN-β in Individuals Afflicted with Multiple Sclerosis Groundbreaking news concerning multiple sclerosis (MS) appeared in the mainstream media earlier this year ...

Despite high vaccine coverage and effectiveness, the incidence of symptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been increasing in Israel. Whether the ...